$REVB

Revelation Biosciences, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA

REVB chart

What traders are saying about $REVB

Latest posts

Revelation Biosciences, Inc. news

Revelation Biosciences, Inc. key financials

USD2025202420232022
Net income-$8.9M-$15.0M-$120,254-$10.8M
Diluted EPS$-23.95$-1052.16$-8.44$-149.20
Total assets (year end)$11.6M$6.6M$12.2M$5.5M
Cash and equivalents (year end)$10.7M$6.5M$12.0M$5.3M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Revelation Biosciences, Inc.

Ticker
REVB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1810560
Former names
Petra Acquisition Inc.

Frequently asked questions

What exchange is Revelation Biosciences, Inc. listed on?

Revelation Biosciences, Inc. trades on the Nasdaq under the ticker symbol REVB.

What industry is Revelation Biosciences, Inc. in?

Revelation Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Revelation Biosciences, Inc. headquartered?

Revelation Biosciences, Inc.'s business address on file with the SEC is in San Diego, CA.

When does Revelation Biosciences, Inc.'s fiscal year end?

Revelation Biosciences, Inc.'s fiscal year ends on December 31.